Table 1 Clinical characteristics of the enrolled population
Clinical characteristics | HC group (n = 29) | HBV group (n = 26) | C. sinensis group (n = 24) | Coinfected group (n = 22) |
|---|---|---|---|---|
Age (years) | 44.86 ± 7.46 | 42.59 ± 12.21 | 42.42 ± 9.11 | 40.73 ± 10.49 |
Gender (male/female) | 26/3 | 23/3 | 22/2 | 20/2 |
HBV DNA (Log copies/ml) | Negative | 4.61 ± 1.91 | Negative | 5.50 ± 1.70 |
ALT (U/l) | 22.00 (9–73) | 62.50 (20–665)***# | 43.50 (3–615)*### | 233.50 (14–733)*** |
AST (U/l) | 22.00 (16–45) | 41.50 (21–401)***# | 31.00 (18–191)*### | 148.50 (21–382)*** |
TB (μmol/l) | 11.00 (2.80–32.64) | 16.30 (6.80–418.00)# | 13.27 (5.00–472.10)## | 51.15 (8.90–626.50)*** |
HA (ng/ml) | 45.17 (30.00–94.85) | 77.93 (30.00–255.35)**# | 67.88 (30.00–1000.00)*# | 131.20 (30.00–1000.00)*** |
PCIII (ng/ml) | 7.37 (5.06–10.86) | 11.00 (4.55–26.11)* | 10.59 (1.50–32.39)** | 7.45 (1.50–31.06) |
LN (ng/ml) | 44.00 (16.23–83.84) | 71.49 (15.00–161.81) | 40.86 (15.00–189.52) | 38.95 (15.00–327.13) |
COLIV (ng/ml) | 34.10 (15.02–86.39) | 52.74 (21.62–1000.00) | 26.90 (15.00–1000.00) | 72.37 (15.00–671.37) |